Rapid Micro Biosystems Inc (RPID) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Earnings Call Summary | Rapid Micro Biosystems(RPID.US) Q1 2024 Earnings Conference
The following is a summary of the Rapid Micro Biosystems, Inc. (RPID) Q1 2024 Earnings Call Transcript:Financial Performance:Rapid Micro Biosystems reported an 11% increase in Q1 total revenue to $5.6
Rapid Micro Biosystems Still Sees Gross Margin Positive for Full-Year 2024 >RPID
Rapid Micro Biosystems Still Sees Gross Margin Positive for Full-Year 2024 >RPID
Rapid Micro Biosystems: Cash Runway at Least Into 2nd Half of 2026 >RPID
Rapid Micro Biosystems: Cash Runway at Least Into 2nd Half of 2026 >RPID
Rapid Micro Biosystems Q1 2024 GAAP EPS $(0.31) Misses $(0.29) Estimate, Sales $5.611M Beat $5.500M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 3.13 percent increase over losses o
Earnings Flash (RPID) RAPID MICRO BIOSYSTEMS Posts Q1 Revenue $5.6M
07:02 AM EDT, 05/03/2024 (MT Newswires) -- Earnings Flash (RPID) RAPID MICRO BIOSYSTEMS Posts Q1 Revenue $5.6M
Rapid Micro Biosystems 1Q Rev $5.61M >RPID
Rapid Micro Biosystems 1Q Rev $5.61M >RPID
Press Release: Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected results for its second quarter.The company announced a $11
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting From March 25 - 27, 2024
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2023 Earnings Call Transcript
Bad News for Rapid Micro Biosystems, Inc. Class A Stock: This New Risk Has Been Added
Rapid Micro Biosystems, Inc. Class A (RPID) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Rapid Micro Biosystems (RPID) Receives a Buy From TD Cowen
Earnings Scheduled For March 1, 2024
Companies Reporting Before The Bell • McEwen Mining (NYSE:MUX) is estimated to report quarterly loss at $0.28 per share on revenue of $71.72 million. • PropertyGuru Group (NYSE:PGRU) is estimated to r
Rapid Micro Biosystems: Q4 Earnings Insights
Rapid Micro Biosystems (NASDAQ:RPID) reported its Q4 earnings results on Friday, March 1, 2024 at 07:00 AM.Here's what investors need to know about the announcement.EarningsRapid Micro Biosystems beat
Rapid Micro Expects FY24 Total Revenue Of At Least $27M Vs. $28.29M Estimate, Including The Placement Of At Least 20 Systems
Rapid Micro Expects FY24 Total Revenue Of At Least $27M Vs. $28.29M Estimate, Including The Placement Of At Least 20 Systems
Rapid Micro Biosystems Q4 EPS $(0.26) Beats $(0.30) Estimate, Sales $6.34M Beat $6.15M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 33.33 percent increase over losses
No Data